. Author manuscript; available in PMC: 2013 Jan 3.

Published in final edited form as: J Perinatol. 2011 Nov 24;32(6):438–442. doi: 10.1038/jp.2011.117

Table 1.

Neonatal outcomes in the two groups.

CHARACTERISTIC		SNIPPV (n=172)	NIPPV (n=238)	p-value
Days on ETT IPPV	Median, (range)	8.5 (0 – 141)	10.5 (0 – 141)	0.67
Days on SNIPPV/NIPPV	Median, (range)	7.5 (1 – 49)	7 (1 – 42)	0.36
Days on NCPAP	Median, (range)	7.5 (0 – 36)	4 (0 – 97)	0.02
Sepsis (early- or late-onset)	N,%	63 (36.6)	73 (30.7)	0.21
PDA	N,%	35 (23.6)	41 (17.2)	0.42
IVH	N,%	31 (18)	46 (19.3)	0.74
PVL	N,%	6 (3.5)	4 (1.7)	0.33
ROP	N,%	72 (41.9)	99 (41.6)	0.95
NEC	N,%	23 (13.4)	27 (11.3)	0.54
Days on TPN	Median, (range)	24 (0 – 120)	21 (0 – 199)	0.05
Length of stay	Median, (range)	70 (5 – 207)	74 (4 – 330)	0.35

ETT/IPPV: endotracheal tube intermittent positive pressure ventilation; SNIPPV/NIPPV: synchronized/nasal intermittent positive pressure ventilation; NCPAP: nasal continuous positive airway pressure; PDA: patent ductus arteriosus; IVH: intraventricular hemorrhage; PVL: periventricular leukomalacia; ROP: retinopathy of prematurity; NEC: necrotizing enterocolitis; TPN: total parenteral nutrition.